Ebola

TWiV 528: Our annual recapsidation

2 Comments / This Week in Virology / By

In the first episode for 2019, the TWiV team reviews the amazing virology stories of the past year. <span data-mce-type=”bookmark” style=”display: inline-block; width: 0px; overflow: hidden; line-height: 0;” class=”mce_SELRES_start”></span>&lt;span data-mce-type=”bookmark” style=”display: inline-block; width: 0px; overflow: hidden; line-height: 0;” class=”mce_SELRES_start”&gt;&lt;/span&gt;&amp;lt;span data-mce-type=”bookmark” style=”display: inline-block; width: 0px; overflow: hidden; line-height: 0;” class=”mce_SELRES_start”&amp;gt;&amp;lt;/span&amp;gt;&amp;amp;lt;span data-mce-type=”bookmark” style=”display: inline-block; width: 0px; overflow: …

TWiV 528: Our annual recapsidation Read More »

Building an Ebola Virus Lab in Sierra Leone with Ian Goodfellow

2 Comments / Basic virology, Information / By

I spoke with virologist Ian Goodfellow, whose laboratory works on noroviruses, about why he went to Sierra Leone to establish an Ebolavirus diagnostic and sequencing laboratory. The obstacles he encountered were considerable, but the results were very useful. Recorded at the Emerging Infectious Diseases A to Z (EIDA2Z) conference hosted by the National Emerging Infectious Diseases Laboratories (NEIDL).

An Ebolavirus vaccine in Africa

11 Comments / Basic virology, Information / By

An Ebolavirus vaccine has shown promising results in a clinical trial in Guinea. This vaccine has been in development since 2004 and was made possible by advances in basic virology of the past 40 years. The ability to produce the Ebolavirus vaccine, called rVSV-EBOV, originates in the 1970s with the discovery of the enzyme reverse transcriptase, the development of …

An Ebolavirus vaccine in Africa Read More »

Long-term effects of Ebolavirus infection

4 Comments / Basic virology, Information / By

The thousands of survivors of the Ebolavirus outbreak in western Africa – more than at any other time – are fortunate to have survived the disease. However, their health problems are not behind them. A new study shows that the survivors of Ebolavirus have long-term sequelae more than 2 years after infection. Acute infections caused …

Long-term effects of Ebolavirus infection Read More »

Ebolavirus will not become a respiratory pathogen

15 Comments / Basic virology, Commentary, Information / By

An otherwise balanced review of selected aspects of Ebolavirus transmission falls apart when the authors hypothesize that ‘Ebola viruses have the potential to be respiratory pathogens with primary respiratory spread.’ The idea that Ebolavirus might become transmitted by the respiratory route was suggested last year by Michael Osterholm in a Times OpEd. That idea was widely criticized …

Ebolavirus will not become a respiratory pathogen Read More »

Scroll to Top